Guideline Updates G25: SIS 2024 Intra-Abdominal Infection Therapy: The Treatment Half of the Belly, and When to Reach for an Antifungal

The Surgical Infection Society 2024 update is the antimicrobial and antifungal therapy companion to IDSA 2024 Part 1, which covered diagnosis only; it advises against empiric antifungals in lower-risk community-acquired infection and recommends anidulafungin for higher-risk Candida intra-abdominal infection, all anchored on adequate source control